Sources and derivations
The published methodology records its sources, derivations, and versioned assumptions. Browse the references and the documented probability adjustments.
About PhaseFolio
Evidence worth carrying into the room.
PhaseFolio helps biotech teams and their partners make a clearer record of the evidence, assumptions, and open questions behind a comparison or diligence case.
The work
Start with the record, not the shortcut.
A biotech question can move through source material, comparisons, diligence notes, and a decision quickly. PhaseFolio keeps the supporting work inspectable: what was found, what it means in context, and what remains unresolved.
Atlas is a comparator-surfacing and evidence-inspection tool. Workspace organizes the diligence case around it. The products support review; they do not provide clinical decision support or replace a team's judgment.
The product family
Different tools for the same line of sight.
Governance
The method stays open to inspection.
Methods and validation
Explore the published backtests, including their findings and limitations, alongside the methods they evaluate.
Verification and platform trust
Use the public verification page for eligible issued artifacts, then review the platform and its operating context and security posture.
People
Built around a disciplined research practice.
Tamal Adebisi
Founder & Methodology Author
MS Finance candidate at Johns Hopkins University and author of the PhaseFolio rNPV methodology, multi-indication backtest framework, engine architecture, and clinical data pipeline.
LinkedIn ↗Jeromie Ballreich, PhD
Scientific & Strategic Advisor
Associate Research Professor in the Department of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health, advising PhaseFolio on valuation methodology and benchmarking.
Find your starting point